fingolimod hydrochloride has been researched along with Cadaver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DomÃnguez, J; Giacaman, A; Lira, F; Mendez, G | 1 |
| Boira, JG; Charpentier, B; Kahan, BD; Madsen, S; Mourad, G; Mulgaonkar, S; Nashan, B; Pellet, P; Tedesco-Silva, H; Vanrenterghem, Y; Weimar, W | 1 |
1 trial(s) available for fingolimod hydrochloride and Cadaver
| Article | Year |
|---|---|
FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
Topics: Adolescent; Adult; Aged; Cadaver; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Propylene Glycols; Safety; Sphingosine; Tissue Donors; Treatment Outcome | 2004 |
1 other study(ies) available for fingolimod hydrochloride and Cadaver
| Article | Year |
|---|---|
Short-term immunossupressive treatment of the donor does not prevent ischemia-reperfusion kidney damage in the rat.
Topics: Animals; Cadaver; Creatinine; Fingolimod Hydrochloride; Graft Survival; Hypertonic Solutions; Immunosuppressive Agents; Kidney Transplantation; Male; Propylene Glycols; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sirolimus; Sphingosine; Tissue Donors | 2011 |